Summers MA - Search Results

1

L-carnitine supplementation for muscle weakness and fatigue in children with neurofibromatosis type 1: A Phase 2a clinical trial.

Vasiljevski ER, Burns J, Bray P, Donlevy G, Mudge AJ, Jones KJ, Summers MA, Biggin A, Munns CF, McKay MJ, Baldwin JN, Little DG, Schindeler A. Vasiljevski ER, et al. Among authors: summers ma. Am J Med Genet A. 2021 Oct;185(10):2976-2985. doi: 10.1002/ajmg.a.62392. Epub 2021 Jun 21. Am J Med Genet A. 2021. PMID: 34155781 Free PMC article. Clinical Trial.

2

Skeletal muscle and motor deficits in Neurofibromatosis Type 1.

Summers MA, Quinlan KG, Payne JM, Little DG, North KN, Schindeler A. Summers MA, et al. J Musculoskelet Neuronal Interact. 2015 Jun;15(2):161-70. J Musculoskelet Neuronal Interact. 2015. PMID: 26032208 Free PMC article. Review.

3

Dietary intervention rescues myopathy associated with neurofibromatosis type 1.

Summers MA, Rupasinghe T, Vasiljevski ER, Evesson FJ, Mikulec K, Peacock L, Quinlan KG, Cooper ST, Roessner U, Stevenson DA, Little DG, Schindeler A. Summers MA, et al. Hum Mol Genet. 2018 Feb 15;27(4):577-588. doi: 10.1093/hmg/ddx423. Hum Mol Genet. 2018. PMID: 29228356

4

Developmental dosing with a MEK inhibitor (PD0325901) rescues myopathic features of the muscle-specific but not limb-specific Nf1 knockout mouse.

Summers MA, Vasiljevski ER, Mikulec K, Peacock L, Little DG, Schindeler A. Summers MA, et al. Mol Genet Metab. 2018 Apr;123(4):518-525. doi: 10.1016/j.ymgme.2018.02.009. Epub 2018 Feb 16. Mol Genet Metab. 2018. PMID: 29477258

5

Lipid storage myopathies: Current treatments and future directions.

Vasiljevski ER, Summers MA, Little DG, Schindeler A. Vasiljevski ER, et al. Among authors: summers ma. Prog Lipid Res. 2018 Oct;72:1-17. doi: 10.1016/j.plipres.2018.08.001. Epub 2018 Aug 9. Prog Lipid Res. 2018. PMID: 30099045 Review.

6

Evaluating modified diets and dietary supplement therapies for reducing muscle lipid accumulation and improving muscle function in neurofibromatosis type 1 (NF1).

Vasiljevski ER, Houweling PJ, Rupasinghe T, Kaur T, Summers MA, Roessner U, Little DG, Schindeler A. Vasiljevski ER, et al. Among authors: summers ma. PLoS One. 2020 Aug 10;15(8):e0237097. doi: 10.1371/journal.pone.0237097. eCollection 2020. PLoS One. 2020. PMID: 32810864 Free PMC article.

7

Limitations of the Pax7-creER^T2 transgene for driving deletion of Nf1 in adult mouse muscle.

Summers MA, Mikulec K, Peacock L, Little DG, Schindeler A. Summers MA, et al. Int J Dev Biol. 2017;61(8-9):531-536. doi: 10.1387/ijdb.170182as. Int J Dev Biol. 2017. PMID: 29139538 Free article.

8

Inducible cell labeling and lineage tracking during fracture repair.

Seime T, Kolind M, Mikulec K, Summers MA, Cantrill L, Little DG, Schindeler A. Seime T, et al. Among authors: summers ma. Dev Growth Differ. 2015 Jan;57(1):10-23. doi: 10.1111/dgd.12184. Epub 2014 Nov 11. Dev Growth Differ. 2015. PMID: 25389084

9

Tumor Cell Dormancy and Reactivation in Bone: Skeletal Biology and Therapeutic Opportunities.

Byrne NM, Summers MA, McDonald MM. Byrne NM, et al. Among authors: summers ma. JBMR Plus. 2019 Jan 7;3(3):e10125. doi: 10.1002/jbm4.10125. eCollection 2019 Mar. JBMR Plus. 2019. PMID: 30918917 Free PMC article. Review.

10

A machine learning model to identify early stage symptoms of SARS-Cov-2 infected patients.

Ahamad MM, Aktar S, Rashed-Al-Mahfuz M, Uddin S, Liò P, Xu H, Summers MA, Quinn JMW, Moni MA. Ahamad MM, et al. Among authors: summers ma. Expert Syst Appl. 2020 Dec 1;160:113661. doi: 10.1016/j.eswa.2020.113661. Epub 2020 Jun 20. Expert Syst Appl. 2020. PMID: 32834556 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33 results

Search Page

Filters